Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1
Aim. The aim of study was to develop and validate a simple, highly robust (quality by design (QbD) approach), precise and accurate method using high performance liquid chromatography for the simultaneous determination of original active pharmaceutical ingredient Quinabut an...
Main Authors: | Оlena Golembiovska, Oleksii Voskoboinik, Galina Berest, Sergiy Kovalenko, Liliya Logoyda |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2021-01-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/50704/download/pdf/ |
Similar Items
-
Method development and validation for the determination of residual solvents in quinabut API by using gas chromatography. Message 2
by: Оlena Golembiovska, et al.
Published: (2021-01-01) -
Development of a Novel, Fast, Simple HPLC Method for Determination of Atorvastatin and Its Impurities in Tablets
by: Nataliia Shulyak, et al.
Published: (2021-04-01) -
Development and validation of a fast and simple HPLC method for the simultaneous determination of bisoprolol and enalapril in dosage form
by: Marjan Piponski, et al.
Published: (2021-01-01) -
Impurity Profiling of Challenging Active Pharmaceutical Ingredients without Chromophore
by: Wahl, Oliver
Published: (2016) -
Simultaneous HPLC Determination of Chlordiazepoxide and Mebeverine HCl in the Presence of Their Degradation Products and Impurities
by: Rania N. El-Shaheny, et al.
Published: (2015-01-01)